$6.91
0.050.73%
Pre-Market: Jan 17, 7:55 PM EDT
Comments
Loading...
Altimmune (NASDAQ:ALT) Stock, Earnings Estimates, EPS, And Revenue
Altimmune reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 26
EPS Estimate
$-0.340
Quarterly Revenue Estimate
$620.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$52.00K
Analyze the earnings history of Altimmune using advanced sorting and filters.
Data brought to you by Benzinga APIs
Altimmune (ALT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.32 | $-0.35 | 8.57 % |
| Q2 | 2024-08-08 | $-0.35 | $-0.34 | -2.94 % |
| Q1 | 2024-05-09 | $-0.34 | $-0.37 | 8.11 % |
| Q4 | 2024-03-27 | $-0.33 | $-0.43 | 23.3 % |
Altimmune (ALT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2023-02-28 | $-110.00K | $30.00K | -466.7 % |
| Q3 | 2022-11-10 | $2.00K | $870.00K | -99.8 % |
| Q2 | 2022-08-11 | $8.00K | $870.00K | -99.1 % |
| Q1 | 2022-05-12 | $32.00K | $1.03M | -96.9 % |
FAQ
When is Altimmune (NASDAQ:ALT) reporting earnings?
Altimmune (ALT) is scheduled to report earnings on March 26, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Altimmune (NASDAQ:ALT)?
The Actual EPS was $-0.32, which beat the estimate of $-0.35.
What were Altimmune’s (NASDAQ:ALT) revenues?
The Actual Revenue was $5K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.